82 FR 57279 - Food and Drug Administration Fiscal Year 2017 Performance Review Board Members

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 82, Issue 231 (December 4, 2017)

The Food and Drug Administration (FDA) is announcing the names of the members who will serve on its Performance Review Board (PRB). The purpose of the PRB is to provide fair and impartial review of senior executive service (SES), senior professional and Title 42(f) SES Equivalents performance appraisals, bonus recommendations, and pay adjustments.

[Federal Register Volume 82, Number 231 (Monday, December 4, 2017)]
[Notices]
[Page 57279]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-26015]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-6475]


Food and Drug Administration Fiscal Year 2017 Performance Review 
Board Members

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the names 
of the members who will serve on its Performance Review Board (PRB). 
The purpose of the PRB is to provide fair and impartial review of 
senior executive service (SES), senior professional and Title 42(f) SES 
Equivalents performance appraisals, bonus recommendations, and pay 
adjustments.

DATES: Effective October 30, 2017.

FOR FURTHER INFORMATION CONTACT: Abu Sesay, Office of Human Resources 
Executive and Resources Management Staff, Food and Drug Administration, 
Three White Flint North, 05C68, 11601 Landsdown St., North Bethesda, MD 
20852, 240-402-0440 (not a toll free number).

SUPPLEMENTARY INFORMATION: This action is being taken pursuant to 5 
U.S.C. 4314(c)(4), which requires that members of performance review 
boards be appointed in a manner to ensure consistency, stability, and 
objectivity in performance appraisals and requires that notice of the 
appointment of an individual to serve as a member be published in the 
Federal Register.
    The following persons will serve on the FDA Performance Review 
Board, which oversees the evaluation of performance appraisals of FDA's 
senior executives:

James Sigg, PRB Chair
Tania Tse, PRB Officiator
Glenda Barfell
Janelle Barth
Vincent Bunning
Mary Beth Clarke
Tracey Forfa
Leslie Kux
Diane Maloney
Edward Margerrison
Lynne Rice
William Tootle

    Dated: November 28, 2017.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2017-26015 Filed 12-1-17; 8:45 am]
BILLING CODE 4164-01-P